Delivery Order SPE2DB20D2104-SPE2DB22FT97L
- Not listed
- This federal contract award is for the delivery of LIDOCAINE 5% PATCH 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $6,672.66 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., on September 18, 2023, with a completion date of September 19, 2023. The contract does not have a set-aside designation, indicating it was competitively awarded. Amerisourcebergen Drug Corp holds a significant...
- This federal contract award is for the delivery of LIDOCAINE 5% PATCH 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, one of the largest pharmaceutical distribution companies. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. This...
- This federal contract award is for the delivery of LIDOCAINE 5% PATCH 30S to the Defense Logistics Agency (DLA). The contract, valued at $3,524.71, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract is a Firm Fixed Price Delivery Order with a completion date of February 23, 2024. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
- This federal contract award is for the delivery of LIDOCAINE 5% PATCH 30S to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, with a ceiling value of $10,845.70. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the period of performance extends through May 20, 2025. The contract is not set aside and was awarded on an open competition basis....
- This federal contract award is for the delivery of LIDOCAINE 5% PATCH 30S medical supplies, with a ceiling value of $12,158.86. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is a Delivery Order under the company's Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a...
- This federal contract award is for the delivery of LIDOCAINE 5% PATCH 30S to the Defense Logistics Agency (DLA), a defense agency. The $9,349.77 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on February 13, 2025, with a completion date of February 14, 2025. The award is not designated as a set-aside contract. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award is for the delivery of LIDOCAINE 5% PATCH 30S to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $22,104.35 and a completion date of December 7, 2023. The contract is a Delivery Order with a Firm Fixed Price pricing type. This award is not associated with a set-aside designation, indicating open competition....
- This federal contract award is for the delivery of LIDOCAINE 5% PATCH 30S medical products to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, with a ceiling value of $3,353.02. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of June 9, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a...
- This federal contract award is for the delivery of LIDOCAINE 5% PATCH 30S to the Defense Logistics Agency (DLA), a defense agency. The $2,268.31 fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on December 23, 2024, with a completion date of December 24, 2024. The contract has no set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award is for the delivery of LIDOCAINE 5% PATCH 30S to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for a ceiling value of $19,124.16. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an Ultimate Completion Date of May 15, 2025. The contract is not set aside and is open to competition. Amerisourcebergen Drug...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB22FT97LDelivery Order
This federal contract award is for the delivery of LIDOCAINE 5% PATCH 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA) under Delivery Order SPE2DB22FT97L. The contract, valued at $1,132.90, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The award does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare programs globally. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000, for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 9/19/22 |